Thousands of donors provide US$30 million to help MAPS get MDMA into Phase 3 trial

A U.S. psychedelics research organization has locked down US$30 million in funding from some notable benefactors to study the efficacy of treating post-traumatic stress disorder (PTSD) with MDMA, colloquially known as Ecstacy or Molly. Read More
Source: tghop